Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M KAPLAN

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Human Gene Therapy|March 1, 1997
Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primateR J McDonald, M J Lukason, O G Raabe, et al.
Journal of Clinical Immunology|March 1, 1996
Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various speciesE V Ruggieri, P J Bugelski, J M Kaplan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primatesA Scaria, J A Sullivan, J A St George, et al.
The American Journal of Physiology|August 5, 1998
Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualinC Jiang, S L Fang, Y F Xiao, et al.
Human Gene Therapy|July 29, 1998
Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potentialJ M Kaplan, S E Pennington, J A St George, et al.
Human Gene Therapy|January 1, 1997
Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lungJ M Kaplan, D Armentano, T E Sparer, et al.
Nature Genetics|March 4, 2000
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosisJ M Kaplan, S H Kim, K N North, et al.
Human Gene Therapy|April 10, 1997
Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lungR K Scheule, J A St George, R G Bagley, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Human Gene Therapy|March 1, 1997
Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primateR J McDonald, M J Lukason, O G Raabe, et al.
Journal of Clinical Immunology|March 1, 1996
Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various speciesE V Ruggieri, P J Bugelski, J M Kaplan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primatesA Scaria, J A Sullivan, J A St George, et al.
The American Journal of Physiology|August 5, 1998
Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualinC Jiang, S L Fang, Y F Xiao, et al.
Human Gene Therapy|July 29, 1998
Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potentialJ M Kaplan, S E Pennington, J A St George, et al.
Human Gene Therapy|January 1, 1997
Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lungJ M Kaplan, D Armentano, T E Sparer, et al.
Nature Genetics|March 4, 2000
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosisJ M Kaplan, S H Kim, K N North, et al.
Human Gene Therapy|April 10, 1997
Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lungR K Scheule, J A St George, R G Bagley, et al.
Pageof 11